Skip to main content
. 2019 Oct 23;11:9049–9055. doi: 10.2147/CMAR.S222882

Figure 5.

Figure 5

Comparison of progression free survival (PFS) of patients with p-stage I small cell lung cancer (SCLC) between the surgical group and chemoradiotherapy group.